Health - Google News: Sanofi's Lantus Insulin More Potent To Maintain Blood Sugar In Type 2 Diabetes - RTT News

Health - Google News Google News

Sanofi's Lantus Insulin More Potent To Maintain Blood Sugar In Type 2 Diabetes - RTT News Oct 5th 2012, 11:24 Economic Times Sanofi's Lantus Insulin More Potent To Maintain Blood Sugar In Type 2 Diabetes RTT News (RTTNews) - French drug giant Sanofi SA (SNY:Quote) on Friday said the new results from its Outcome Reduction with Initial Glargine Intervention or ORIGIN trial showed that treatment with Lantus was approximately 3 times more likely to achieve and ... More Data Refute Breast Cancer Tie to InsulinMedPage Today Sanofi Presents New Results From ORIGIN Trial - Quick FactsNASDAQ SANOFI: Test Shows Lantus Efficient in Reaching Certain Glycemic Levels4-traders Yahoo! News (blog) -Clinical Endocrinology News Digital Network -Business Recorder (blog) all 30 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: